[go: up one dir, main page]

SE0000514D0 - A 52 kDa protein from coagulase negative staphylococci and fragments - Google Patents

A 52 kDa protein from coagulase negative staphylococci and fragments

Info

Publication number
SE0000514D0
SE0000514D0 SE0000514A SE0000514A SE0000514D0 SE 0000514 D0 SE0000514 D0 SE 0000514D0 SE 0000514 A SE0000514 A SE 0000514A SE 0000514 A SE0000514 A SE 0000514A SE 0000514 D0 SE0000514 D0 SE 0000514D0
Authority
SE
Sweden
Prior art keywords
protein
fragments
antigen
antibodies
vector
Prior art date
Application number
SE0000514A
Other languages
English (en)
Inventor
Aasa Ljungh
Dai-Quing Li
Fredrik Lundberg
Original Assignee
Biostapro Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biostapro Ab filed Critical Biostapro Ab
Priority to SE0000514A priority Critical patent/SE0000514D0/sv
Publication of SE0000514D0 publication Critical patent/SE0000514D0/sv
Priority to EP01906475A priority patent/EP1261631A1/en
Priority to AU2001234299A priority patent/AU2001234299A1/en
Priority to JP2001560235A priority patent/JP2003523191A/ja
Priority to PCT/SE2001/000340 priority patent/WO2001060852A1/en
Priority to US10/203,613 priority patent/US20030082200A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE0000514A 2000-02-17 2000-02-17 A 52 kDa protein from coagulase negative staphylococci and fragments SE0000514D0 (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE0000514A SE0000514D0 (sv) 2000-02-17 2000-02-17 A 52 kDa protein from coagulase negative staphylococci and fragments
EP01906475A EP1261631A1 (en) 2000-02-17 2001-02-16 A 52 kDa PROTEIN FROM COAGULASE NEGATIVE STAPHYLOCOCCI AND FRAGMENTS THEREOF
AU2001234299A AU2001234299A1 (en) 2000-02-17 2001-02-16 A 52 kda protein from coagulase negative staphylococci and fragments thereof
JP2001560235A JP2003523191A (ja) 2000-02-17 2001-02-16 コアグラーゼ陰性ブドウ球菌からの５２ｋＤａ蛋白質及びそのフラグメント
PCT/SE2001/000340 WO2001060852A1 (en) 2000-02-17 2001-02-16 A 52 kDa PROTEIN FROM COAGULASE NEGATIVE STAPHYLOCOCCI AND FRAGMENTS THEREOF
US10/203,613 US20030082200A1 (en) 2000-02-17 2001-02-16 52 kda protein from coagulase negative staphylococci and fragments thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0000514A SE0000514D0 (sv) 2000-02-17 2000-02-17 A 52 kDa protein from coagulase negative staphylococci and fragments

Publications (1)

Publication Number Publication Date
SE0000514D0 true SE0000514D0 (sv) 2000-02-17

Family

ID=20278484

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0000514A SE0000514D0 (sv) 2000-02-17 2000-02-17 A 52 kDa protein from coagulase negative staphylococci and fragments

Country Status (6)

Country Link
US (1) US20030082200A1 (sv)
EP (1) EP1261631A1 (sv)
JP (1) JP2003523191A (sv)
AU (1) AU2001234299A1 (sv)
SE (1) SE0000514D0 (sv)
WO (1) WO2001060852A1 (sv)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8729013B2 (en) 2004-08-26 2014-05-20 The University Of Western Ontario Methods of inhibiting staphylobactin-mediated iron uptake in S. aureus
JP2008513406A (ja) 2004-09-22 2008-05-01 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 免疫原性組成物
US20100021503A1 (en) 2006-03-30 2010-01-28 Glaxosmithkline Biologicals S.A. Immunogenic composition
CA2684570A1 (en) 2007-04-19 2008-10-30 Molecular Detection Inc. Methods, compositions and kits for detection and analysis of antibiotic-resistant bacteria
JP5658564B2 (ja) 2007-08-31 2015-01-28 ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ ブドウ球菌肺疾患および状態に対する免疫に関連した方法および組成物
US9181329B2 (en) 2007-08-31 2015-11-10 The University Of Chicago Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions
US8758765B2 (en) 2008-07-29 2014-06-24 The University Of Chicago Compositions and methods related to Staphylococcal bacterium proteins
WO2010042481A1 (en) 2008-10-06 2010-04-15 University Of Chicago Compositions and methods related to bacterial eap, emp, and/or adsa proteins
CN102612523B (zh) 2009-04-03 2016-01-20 芝加哥大学 与蛋白a(spa)变体相关的组合物和方法
GB0913680D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
EP2555794A4 (en) 2010-04-05 2014-01-15 Univ Chicago COMPOSITIONS AND METHODS RELATING TO PROTEIN A (SPA) ANTIBODIES AS IMMUNE REACTION AMPLIFIERS
KR20130093084A (ko) 2010-07-02 2013-08-21 더 유니버시티 오브 시카고 단백질 Ａ(ＳｐＡ) 변이체와 관련된 조성물 및 방법
WO2012034067A1 (en) 2010-09-09 2012-03-15 The University Of Chicago Methods and compositions involving protective staphylococcal antigens
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
CN103906535B (zh) 2011-08-15 2017-07-14 芝加哥大学 与葡萄球菌蛋白a的抗体相关的组合物和方法
CN102952067A (zh) * 2011-08-30 2013-03-06 苏州欣诺科生物科技有限公司 用于蛋白质n端聚乙二醇修饰的吡哆醛衍生物、制备方法及其应用
US9701738B2 (en) 2012-04-26 2017-07-11 The University Of Chicago Compositions and methods related to antibodies that neutralize coagulase activity during Staphylococcus aureus disease
CN104768572B (zh) 2012-04-26 2021-08-24 芝加哥大学 葡萄球菌凝固酶抗原及其使用方法
CA3155424A1 (en) 2019-10-02 2021-04-08 Janssen Vaccines & Prevention B.V. Staphylococcus peptides and methods of use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9402490D0 (sv) * 1994-07-15 1994-07-15 Jan Ingmar Flock Vitronection binding protein

Also Published As

Publication number Publication date
WO2001060852A1 (en) 2001-08-23
EP1261631A1 (en) 2002-12-04
AU2001234299A1 (en) 2001-08-27
JP2003523191A (ja) 2003-08-05
US20030082200A1 (en) 2003-05-01

Similar Documents

Publication Publication Date Title
SE0000514D0 (sv) A 52 kDa protein from coagulase negative staphylococci and fragments
JP2009520758A5 (sv)
EA199800046A1 (ru) Полипептид, последовательность днк, вакцинная композиция (варианты), антитело или его фрагмент, вакцина, применения указанных полипептида, последовательности днк и антитела или его фрагмента
MX9702714A (es) Produccion de peptidos en plantas como fusiones de proteinas con revestimiento viral.
CA2450939A1 (en) Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
Ovchinnikov et al. Topology of Na+, K+-ATPase Identification of the extra-and intracellular hydrophilic loops of the catalytic subunit by specific antibodies
HRP20161305T1 (hr) Liječenje mikrobnih infekcija
JP2010512792A5 (sv)
CA2371714A1 (en) Streptococcus pneumoniae proteins and vaccines
DK1194560T3 (da) Antigene Neisseria-peptider
CN1610697A (zh) 戊型肝炎病毒单克隆抗体或其结合活性片段及其用途
RU2001134170A (ru) Антигенные пептиды NEISSERIA
RU2004108115A (ru) Рекомбинантные антитела и композиции, а также способы их создания и использования
EP0395706A4 (en) Production of gonorrheal pi proteins and vaccines
KR970070198A (ko) 항-파스 재조합 항체 및 이에 대한 디엔아이
DK1417222T3 (da) Isolerede polypeptider baseret på den neutraliserende epitop af p17-proteinet fra HIV egnet til vacciner samt neutraliserende anti-p17-antistoffer, der specifikt genkender nævnte neutraliserende epitop
Ahuja et al. Rapid purification of recombinant anthrax-protective antigen under nondenaturing conditions
JP2002513802A5 (sv)
EP2374466A1 (en) Protective staphylococcus aureus vaccine based on cell wall-associated proteins
CA2353802A1 (en) New protective antigen of group a streptococci
US20020081304A1 (en) Type f botulinum toxin and use thereof
JPWO2020071554A5 (sv)
JP2021505525A5 (sv)
PE20010237A1 (es) GEN DERIVADO DE LAWSONIA Y POLIPEPTIDOS OmpH, PEPTIDOS Y PROTEINAS RELACIONADOS Y SUS USOS
EP1090995A3 (en) Mycoplasma hyopneumoniae antigen MHP3, gene encoding it and uses thereof